In July 2018, GALVmed’s partner ¬†Boehringer Ingelheim launched a new project known as The Last Mile Initiative. The project is designed to address weak distribution channels and help smallholder farmers in Africa increase their knowledge on disease prevention and treatment. While the Last Mile Initiative was initially launched in Kenya, there are plans to expand to key markets throughout Africa including Benin, Burkina Faso, Cameroon, Chad, Ethiopia, Mali, Nigeria and Tanzania, amongst others.

Video courtesy of Boehringer Ingelheim.